One of the Listed companies, Orion Pharma Limited has recommended 10% cash Dividend for the year ended December 31, 2022.
In terms of financial performance, The Company has further informed Consolidated EPS of Tk. 2.74 for the year ended June 30, 2023. The Company has also reported Consolidated NAV per share (Including Revaluation Surplus) of Tk. 88.99, Consolidated NAV per share (Excluding Revaluation Surplus) of Tk. 81.15.
The Annual General Meeting (AGM) & Extraordinary General Meeting (EGM) of the company will be held on December 26, through the digital platform. The record date for this has been fixed at December 3.
Share this
